European Union is implementing drastic transparency measures to ensure pharmaceutical companies deliver their COVID-19 vaccines on time.
These measures, which include strict export controls, have prompted concerns from Canadian officials that the added pressures could reverberate across the country, furthering vaccine shipment delays.Vaccine rollouts in the EU have been slow compared to other countries and hampered by problems, including interruptions to their supply chains.Meanwhile, Canada has also been criticized for its sluggish vaccination campaign.
As of Feb. 1, Canada had administered nearly 1 million doses — representing less than 2 per cent of the country’s population.